Q32 Bio (QTTB) Free Cash Flow Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 48.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.79% |
| Dec 31, 2025 | 34.49% |
| Sep 30, 2025 | 78.62% |
| Jun 30, 2025 | 53.63% |
| Mar 31, 2025 | 13.21% |
| Dec 31, 2024 | -1.74% |
| Sep 30, 2024 | -222.96% |
| Jun 30, 2024 | -94.13% |
| Mar 31, 2024 | -17.32% |
| Dec 31, 2023 | 60.62% |
| Sep 30, 2023 | 164.53% |
| Jun 30, 2023 | 63.95% |
| Mar 31, 2023 | 59.34% |
| Dec 31, 2022 | 11.19% |
| Sep 30, 2022 | 1.54% |
| Jun 30, 2022 | -37.07% |
| Mar 31, 2022 | -0.34% |
| Dec 31, 2021 | -242.54% |
| Sep 30, 2021 | 12.80% |
| Jun 30, 2021 | 22.56% |
| Mar 31, 2021 | -16.72% |
| Dec 31, 2020 | 65.74% |
| Sep 30, 2020 | -196.94% |
| Jun 30, 2020 | 7.86% |
| Mar 31, 2020 | -13.42% |
| Dec 31, 2019 | -8.73% |
| Sep 30, 2019 | 47.18% |
| Jun 30, 2019 | -135.77% |
| Mar 31, 2019 | -109.06% |
| Dec 31, 2018 | -210.58% |
| Sep 30, 2018 | -167.46% |
| Jun 30, 2018 | -184.13% |
| Mar 31, 2018 | -106.04% |